Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
The scientific breakthrough behind Zokinvy (lonafarnib), the first FDA-approved drug for Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic aging disease.